Integra LifeSciences Holdings Corporation (IART) Social Stream
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering INTEGRA LIFESCIENCES HOLDINGS CORP.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-05 | 8 | $88 | $72 | $80.166 | $41.41 | 93.59% |
| 2021-11-10 | 8 | $88 | $55.001 | $76.571 | $41.41 | 84.91% |
| 2022-01-06 | 8 | $88 | $55 | $76.571 | $41.41 | 84.91% |
| 2022-01-18 | 7 | $88 | $65 | $77.666 | $41.41 | 87.55% |
| 2022-02-24 | 8 | $88 | $65 | $73.5 | $41.41 | 77.49% |
| 2022-04-27 | 8 | $80 | $65 | $72 | $41.41 | 73.87% |
| 2022-04-28 | 8 | $80 | $65 | $70.833 | $41.41 | 71.05% |
| 2022-05-17 | 7 | $78 | $65 | $68.666 | $41.41 | 65.82% |
| 2022-07-25 | 8 | $78 | $55 | $63.857 | $41.41 | 54.21% |
| 2022-07-28 | 8 | $70 | $55 | $61 | $41.41 | 47.31% |
| 2022-07-29 | 8 | $70 | $55 | $62.428 | $41.41 | 50.76% |
| 2022-08-24 | 8 | $70 | $55 | $61.285 | $41.41 | 48% |
| 2022-09-14 | 8 | $70 | $50 | $60.428 | $41.41 | 45.93% |
| 2022-09-17 | 7 | $70 | $50 | $60.428 | $41.41 | 45.93% |
| 2022-10-05 | 7 | $70 | $50 | $58 | $41.41 | 40.06% |
| 2022-10-11 | 8 | $70 | $49 | $56.714 | $41.41 | 36.96% |
| 2022-10-12 | 8 | $70 | $48 | $55.625 | $41.41 | 34.33% |
| 2022-10-17 | 8 | $70 | $46 | $53.875 | $41.41 | 30.1% |
| 2022-10-21 | 8 | $66 | $46 | $51.75 | $41.41 | 24.97% |
| 2022-12-02 | 9 | $75 | $48 | $54.777 | $41.41 | 32.28% |
| 2022-12-12 | 10 | $75 | $48 | $55.888 | $41.41 | 34.96% |
| 2022-12-15 | 10 | $75 | $50 | $56.777 | $41.41 | 37.11% |
| 2022-12-20 | 10 | $75 | $50 | $57.444 | $41.41 | 38.72% |
| 2023-01-06 | 10 | $75 | $50 | $58.444 | $41.41 | 41.13% |
| 2023-02-17 | 10 | $75 | $50 | $59.111 | $41.41 | 42.75% |
| 2023-03-03 | 10 | $75 | $50 | $59.777 | $41.41 | 44.35% |
| 2023-04-26 | 10 | $75 | $50 | $60.222 | $41.41 | 45.43% |
| 2023-05-15 | 10 | $66 | $50 | $58.444 | $41.41 | 41.13% |
| 2023-05-18 | 10 | $66 | $50 | $58 | $41.41 | 40.06% |
| 2023-05-23 | 10 | $66 | $39 | $55.777 | $41.41 | 34.69% |
| 2023-05-24 | 10 | $65 | $39 | $52.111 | $41.41 | 25.84% |
| 2023-06-06 | 11 | $65 | $39 | $49.222 | $41.41 | 18.87% |
| 2023-06-23 | 11 | $65 | $39 | $48 | $41.41 | 15.91% |
| 2023-07-12 | 11 | $65 | $39 | $47.444 | $41.41 | 14.57% |
| 2023-07-19 | 11 | $65 | $39 | $47.888 | $41.41 | 15.64% |
| 2023-07-28 | 11 | $60 | $39 | $47.555 | $41.41 | 14.84% |
| 2023-08-13 | 11 | $60 | $39 | $47.222 | $41.41 | 14.04% |
| 2023-08-24 | 11 | $60 | $39 | $47.222 | $41.41 | 14.04% |
| 2023-10-13 | 11 | $60 | $39 | $46.444 | $41.41 | 12.16% |
| 2023-10-26 | 11 | $60 | $39 | $44.777 | $41.41 | 8.13% |
| 2023-10-27 | 13 | $60 | $38 | $44.1 | $41.41 | 6.5% |
| 2023-11-14 | 13 | $60 | $38 | $44.636 | $41.41 | 7.79% |
| 2023-12-13 | 13 | $60 | $37 | $44.818 | $41.41 | 8.23% |
| 2023-12-19 | 12 | $55 | $37 | $45.3 | $41.41 | 9.39% |
| 2023-12-21 | 12 | $57 | $37 | $46 | $41.41 | 11.08% |
| 2023-12-22 | 12 | $57 | $37 | $46.2 | $41.41 | 11.57% |
The Trend in the Analyst Price Target
IART's average price target has moved down $22.8 over the prior 20 months.
Over the past 50 weeks, IART's average upside potential has been 14.83%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-27 | 10 | 66 | 50 | 58.444 | 55.22 | 5.84% |
| 2023-07-19 | 11 | 65 | 39 | 47.888 | 44.95 | 6.54% |
| 2023-10-27 | 12 | 60 | 38 | 44.100 | 34.21 | 28.91% |
| 2023-12-21 | 12 | 57 | 37 | 46.000 | 44.36 | 3.7% |
| 2023-12-22 | 12 | 57 | 37 | 46.200 | 44.59 | 3.61% |
IART Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.73 | 4 | 1 | 3 | 2 | 2 | 12 |
The Trend in the Broker Recommendations
IART's average broker recommendation rating improved by 0.11 over the prior 19 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for IART as an investment opportunity.
- IART has a higher average analyst price target than 3816.86% of stocks in the mid market cap category.
- IART has a greater number of analysts covering the stock than 3704.89% of stocks in the mid market cap category.
- INTEGRA LIFESCIENCES HOLDINGS CORP's variance in analysts' estimates is lower than -1753.16% of Healthcare stocks.
- INTEGRA LIFESCIENCES HOLDINGS CORP's upside potential (average analyst target price relative to current price) is higher than 1943.15% of Healthcare stocks.
In the Medical Equipment industry, MMSI, HAE, and NARI are the three stocks most similar to INTEGRA LIFESCIENCES HOLDINGS CORP regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is IART a Buy, Hold or Sell? See the POWR Ratings now!